NASDAQ:CYNO Cynosure (CYNO) Stock Price, News & Analysis → [URGENT] DO NOT Touch These AI Stocks! (From Weiss Ratings) (Ad) Free CYNO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$66.00▼$66.0050-Day Range N/A52-Week Range$39.90▼$66.65VolumeN/AAverage Volume1.24 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Cynosure alerts: Email Address Ad Manward PressThis unknown company solves the biggest issue with AINvidia is the 800-lb gorilla in AI chips. But… it has a big problem. That's where one tiny company comes in. Discover why this company About Cynosure Stock (NASDAQ:CYNO)Cynosure, Inc. develops, manufactures and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve women's health. The Company also markets radiofrequency (RF), energy-sourced medical devices for surgical applications, such as facial plastic and general surgery, gynecology, ear, nose, and throat procedures, ophthalmology, oral and maxillofacial surgery, podiatry and proctology. The Company sells its products globally under the Cynosure, Palomar, ConBio and Ellman brand names. Its product portfolio includes single energy source systems, as well as workstations that incorporate two or more different types of lasers or light-based technologies.Read More Ad Manward PressThis unknown company solves the biggest issue with AINvidia is the 800-lb gorilla in AI chips. But… it has a big problem. That's where one tiny company comes in. Discover why this company CYNO Stock News HeadlinesMay 14 at 7:47 PM | msn.comIn Amethi, Modi factor keeps Smriti Irani afloat, Gandhi hand steadies aide’s boatMay 14 at 7:47 PM | msn.comTwo presidents: Impact on midterm electionsMay 13 at 10:31 AM | msn.comSuperstar Mahesh Babu's Long Locks, Physique Biggest Attraction!May 12 at 7:27 PM | msn.comRashmika Mandanna Has An Exciting Line Up Of Films: Have A Look!May 11, 2024 | msn.comIPL 2024: RCB eye top-notch show against DC at M. Chinnaswamy StadiumMay 9, 2024 | msn.comNigerian Press Council boss, Ezughah, sues for national unityMay 8, 2024 | msn.comNigerian Press Council boss sues for national unityMay 8, 2024 | msn.com9 Best Things to Do in Anchorage, AlaskaMay 7, 2024 | msn.com10-year-old selling rolls after father’s death melts internet, finds help galoreMay 6, 2024 | msn.comHuge blow for MI as Rohit departs soon after Kishan`s dismissalMay 4, 2024 | theguardian.comNotable Speech wins 2,000 Guineas as favourite City Of Troy slumpsMay 4, 2024 | msn.comWill Mangalagiri weavers spin favourabe poll narrative for Chandrababu's son Lokesh this time?May 2, 2024 | msn.comIt's back: York's giant Ferris wheel returns for bank holiday weekendMay 1, 2024 | msn.comDignitaries, others join Mark Okonkwo to bury grand mum in styleMay 1, 2024 | msn.comPresident Federation Cup: Excitement as round of 64 games begins todayApril 30, 2024 | msn.comI Was Terrified of Laser Hair Removal But Finally Did It—Here's Exactly What It's LikeApril 30, 2024 | msn.comAt 71.27%, Kerala LS polls’ voter turnout records dip from ’19April 30, 2024 | msn.comHyderabad's Malkajgiri: Where North meets East and West in the SouthApril 27, 2024 | msn.comIs Nelly Korda's Historic Effort Going In Vain? Dark Reality Buries Dominant Women's Golf NarrativeApril 27, 2024 | msn.comFans Rave About Nayanthara’s All-Black Ensemble at GQ EventApril 22, 2024 | msn.comSidhu serves 'justice' to Virat Kohli over no-ball row, calls out MCC for 'legalising beamer' via 3 hard-hitting pointsApril 20, 2024 | msn.comCaleb varsity founder lauds Tinubu’s education policiesApril 19, 2024 | msn.comTompolo Cynosure Still Shows, Leads 2024 Amasekumor Festival To Remarkable EndApril 19, 2024 | msn.comActors Siddharth, Aditi Rao Make Their First Public Appearance Together After EngagementApril 19, 2024 | msn.comFederation Cup: Insurance begin title defence against StormersSee More Headlines Receive CYNO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cynosure and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/26/2016Today5/15/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:CYNO CUSIP23257720 CIK885306 Webwww.cynosure.com Phone+1-978-2564200FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report CYNO Stock Analysis - Frequently Asked Questions How were Cynosure's earnings last quarter? Cynosure, Inc. (NASDAQ:CYNO) issued its quarterly earnings data on Tuesday, July, 26th. The medical equipment provider reported $0.36 EPS for the quarter, beating analysts' consensus estimates of $0.29 by $0.07. The medical equipment provider had revenue of $110.30 million for the quarter, compared to analyst estimates of $101.31 million. The business's revenue was up 31.8% on a year-over-year basis. During the same period in the prior year, the company posted $0.30 EPS. What other stocks do shareholders of Cynosure own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cynosure investors own include Global Blood Therapeutics (GBT), Hawkins (HWKN), DHT (DHT), NVIDIA (NVDA), Xtrackers California Municipal Bond ETF (CA), Golar LNG Partners (GMLP), Micron Technology (MU), Endologix (ELGX), BlackRock (BLK) and Chipotle Mexican Grill (CMG). This page (NASDAQ:CYNO) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAmazon's betting big on this unknown AI companyManward PressWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersDems have chosen Biden replacement?Paradigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityAmerica’s worst nightmare?Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cynosure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.